OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perampanel: Does it have broad‐spectrum potential?
Heidrun Potschka, Eugen Trinka
Epilepsia (2018) Vol. 60, Iss. S1, pp. 22-36
Open Access | Times Cited: 72

Showing 26-50 of 72 citing articles:

Pharmacokinetics, tolerability, and clinical effectiveness of perampanel in Japanese patients with epilepsy
Yoshiaki Yamamoto, Yuka Shiratani, Shoko Asai, et al.
Seizure (2020) Vol. 83, pp. 181-186
Open Access | Times Cited: 16

Effects of the noncompetitive AMPA receptor antagonist perampanel on thalamo-cortical excitability: A study of high-frequency oscillations in somatosensory evoked potentials
Jacopo Lanzone, Marilisa Boscarino, Lorenzo Ricci, et al.
Clinical Neurophysiology (2021) Vol. 132, Iss. 5, pp. 1049-1056
Closed Access | Times Cited: 14

Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System
Carmen De, Claudia Cristiano, Carmen Avagliano, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 13

Positive and negative AMPA receptor modulators based on tricyclic bispidine derivative: Minor structural change inverts the type of activity
Mstislav I. Lavrov, Polina N. Veremeeva, Elena A. Golubeva, et al.
Mendeleev Communications (2022) Vol. 32, Iss. 3, pp. 360-363
Closed Access | Times Cited: 10

Use of perampanel in children with refractory epilepsy of genetic aetiology
Rui Qu, Yuanyuan Dai, Xiangju Qu, et al.
Epileptic Disorders (2022) Vol. 24, Iss. 4, pp. 687-695
Closed Access | Times Cited: 10

Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements
Paolo Bonanni, Antonio Gambardella, Paolo Tinuper, et al.
BMC Neurology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 12

Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity—In Vitro and In Vivo Studies
Gniewomir Latacz, Kinga Sałat, Anna Furgała, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 875-875
Open Access | Times Cited: 8

Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practice
Eugen Trinka, Taoufik Alsaadi, Hiroko Goji, et al.
Epilepsia (2023) Vol. 64, Iss. 8, pp. 2094-2107
Open Access | Times Cited: 4

Parkinson’s disease, epilepsy, and amyotrophic lateral sclerosis—emerging role of AMPA and kainate subtypes of ionotropic glutamate receptors
Marina N. Vukolova, Laura Y. Yen, Margarita I. Khmyz, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 4

Investigating the Effects of Perampanel on Autophagy-mediated Regulation of GluA2 and PSD95 in Epilepsy
Dan Li, Na Sun, Yingying Guo, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 9210-9221
Closed Access | Times Cited: 1

Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study
Adam Strzelczyk, Marta Maschio, Max C. Pensel, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 3, pp. 825-855
Open Access | Times Cited: 1

Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary Mechanisms
Shengying Lou, Sunliang Cui
Current Medicinal Chemistry (2021) Vol. 29, Iss. 19, pp. 3366-3391
Closed Access | Times Cited: 8

Utility and Safety of Perampanel in Pediatric FIRES and Other Drug-Resistant Epilepsies
Guo Yong Lim, C-L Chen, Derrick Chan Wei Shih
Child Neurology Open (2021) Vol. 8
Open Access | Times Cited: 8

Interindividual Variability of Anticonvulsant-Induced QT Prolongation Risk
N. M. Zhuravlev, N. А. Shnayder, E. E. Vaiman, et al.
Personalized Psychiatry and Neurology (2022) Vol. 2, Iss. 1, pp. 22-45
Open Access | Times Cited: 6

Efficacy and tolerability of perampanel in patients with seizures in real-world clinical practice: A systematic review and meta-analysis
Liyan Hou, Jingjing Yang, Xuan Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3

Exacerbation of Repetitive Falls Due to Atonic Seizures Following Perampanel Administration
Akiko Maeda, Shuichiro Neshige, Riho Katsumata, et al.
Cureus (2023)
Open Access | Times Cited: 3

Epilepsy in Asia
Eugen Trinka, Byungin Lee
Epilepsia (2019) Vol. 60, Iss. S1, pp. 5-6
Open Access | Times Cited: 8

Ligands of the AMPA-subtype glutamate receptors: mechanisms of action and novel chemotypes
Eugene V. Radchenko, Anna Tarakanova, Dmitry S. Karlov, et al.
Biomeditsinskaya Khimiya (2021) Vol. 67, Iss. 3, pp. 187-200
Open Access | Times Cited: 7

Influence of the TARP γ8-Selective Negative Allosteric Modulator JNJ-55511118 on AMPA Receptor Gating and Channel Conductance
Ian D. Coombs, Craig A. Sexton, Stuart Cull-Candy, et al.
Molecular Pharmacology (2022) Vol. 101, Iss. 5, pp. 343-356
Open Access | Times Cited: 5

Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis
Kseniya N. Sedenkova, Denis V. Zverev, Анна Назарова, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8252-8252
Open Access | Times Cited: 4

Perampanel therapy for intractable GRIN2D-related developmental and epileptic encephalopathy: A case report and literature review
Jiaqing Li, Yalan Zhou, Tangfeng Su, et al.
Brain and Development (2022) Vol. 45, Iss. 4, pp. 237-243
Closed Access | Times Cited: 4

Scroll to top